文献速递神经肿瘤

RASL11A被鉴定为赋予胶质母细胞瘤放射敏感性的基因

Identification of RASL11A as a gene conferring radiosensitivity in glioblastoma.
PubMed 文献 · J Neurooncol · 2025-04-01

本研究分析TCGA中699例不同级别胶质瘤样本的mRNA-seq数据,发现RASL11A高表达与临床结局差相关。在U251细胞过表达、U87细胞敲除RASL11A后,体外和体内实验显示RASL11A降低放射敏感性,机制涉及增强STAT3磷酸化。

要点

  • TCGA 699例胶质瘤mRNA-seq分析显示RASL11A高表达与临床结局差相关。
  • 体外实验显示RASL11A高水平细胞在X线照射后克隆存活增加、G2/M阻滞减少、γ-H2AX降低、凋亡率降低。
  • 体内实验显示过表达RASL11A的U251肿瘤照射后体积和重量更大,C-Caspase 3降低、Ki67升高。

核心结论

  • RASL11A似乎通过增强STAT3磷酸化降低胶质母细胞瘤细胞的放射敏感性,提示其作为优化放疗疗效的潜在治疗靶点。

研究设计与样本

  • 分析TCGA中699例不同级别人类胶质瘤样本的mRNA-seq数据,探讨RASL11A表达与临床结局的关系。
  • 在U251细胞中过表达RASL11A、在U87细胞中敲除RASL11A,并进行体外和体内实验评估其对放射敏感性的影响。
  • 对胶质母细胞瘤细胞照射后进行转录组测序并评估p-STAT3水平。

主要发现

  • TCGA 699例胶质瘤样本mRNA-seq分析显示,RASL11A表达较高与临床结局差相关。
  • 体外实验显示,U251细胞过表达RASL11A或U87细胞敲除RASL11A显著影响放射敏感性。
  • RASL11A水平较高的细胞在X线照射后克隆存活增加、G2/M阻滞减少、γ-H2AX水平降低、凋亡率降低。
  • 体内研究显示,过表达RASL11A的U251肿瘤经照射后肿瘤体积和重量更大,C-Caspase 3水平降低、Ki67表达升高。
  • 照射后RASL11A较高改变转录组景观并促进胶质母细胞瘤细胞中STAT3磷酸化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radioresistance poses a significant challenge in the treatment of glioblastoma (GBM). This study investigates the role of Ras-like protein family member 11 A (RASL11A), which is upregulated in GBM cells following X-ray irradiation (IR), in modulating radiosensitivity. MATERIALS AND METHODS: The mRNA-seq data comprising 699 human glioma samples of different grades from The Cancer Genome Atlas (TCGA) was analyzed to explore the relationship between RASL11A expression and clinical outcomes in glioma patients. RASL11A was overexpressed in U251 cells and knocked out in U87 cells, with subsequent assays to evaluate its impacts on radiosensitivity in vitro and in vivo. Transcriptome sequencing was performed and p-STAT3 levels were assessed in GBM cells following IR treatment. RESULTS: Analysis of mRNA-seq data from 699 glioma samples in The Cancer Genome Atlas (TCGA) revealed that higher RASL11A expression correlates with poor clinical outcomes. In vitro experiments demonstrated that RASL11A overexpression in U251 cells or RASL11A knockout in U87 cells significantly affected radiosensitivity. Cells with higher RASL11A levels exhibited increased clonogenic survival, reduced G2/M arrest, decreased γ-H2AX levels, and lower apoptosis rates after X-ray IR. In vivo studies corroborated these findings, showing larger tumor volumes and weights, along with decreased levels of C-Caspase 3 and increased Ki67 expression in RASL11A-overexpressing U251 tumors with IR treatment. Higher RASL11A altered the transcriptome landscape and promoted STAT3 phosphorylation in GBM cells following IR exposure. CONCLUSIONS: RASL11A appears to reduce radiosensitivity by enhancing STAT3 phosphorylation in GBM cells, highlighting its potential as a therapeutic target for optimizing radiotherapy efficacy.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Lan R, Zhang N, Chen R, et al. Identification of RASL11A as a gene conferring radiosensitivity in glioblastoma. J Neurooncol. 2025. PMID: 40167966. doi:10.1007/s11060-025-05013-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。